JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4276
WisdomTree International Quality Dividend Growth Fund
IQDG
$688M
| $513K | ﹤0.01% |
15,150
+437
| +3% | +$14.3K |
2022 Q3
2 quarters
|
|
|
CWBC
4277
Community West Bancshares
CWBC
$715M
| $513K | ﹤0.01% |
24,927
+22,892
| +1,125% | +$532K |
2016 Q2
27 quarters
|
|
|
APGB
4278
DELISTED
Apollo Strategic Growth Capital II
APGB
| $513K | ﹤0.01% |
+50,003
| New | +$507K |
2023 Q1
0 quarters
|
|
4279
Schwab Fundamental US Small Company Index ETF
FNDA
$8.83B
| $512K | ﹤0.01% |
21,074
-52
| -0.2% | -$1.3K |
2018 Q2
19 quarters
|
|
4280
Cellebrite
CLBT
$2.86B
| $512K | ﹤0.01% |
84,013
+18,435
| +28% | +$99.9K |
2021 Q3
6 quarters
|
|
|
EOCW
4281
DELISTED
Elliott Opportunity II Corp.
EOCW
| $512K | ﹤0.01% |
+50,000
| New | +$508K |
2023 Q1
0 quarters
|
|
4282
CALL
Bloom Energy
BE
$87.1B
| $510K | ﹤0.01% |
25,600
| – | – |
2022 Q3
2 quarters
|
|
4283
Goldman Sachs Access Inflation Protected USD Bond ETF
GTIP
$292M
| $510K | ﹤0.01% |
10,140
-2,720
| -21% | -$134K |
2022 Q4
1 quarter
|
|
4284
Commercial Vehicle Group
CVGI
$120M
| $509K | ﹤0.01% |
69,750
+69,739
| +633,991% | +$529K |
2020 Q3
10 quarters
|
|
4285
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$4.84B
| $507K | ﹤0.01% |
6,864
-544
| -7% | -$41K |
2018 Q1
20 quarters
|
|
4286
Global X SuperDividend US ETF
DIV
$762M
| $507K | ﹤0.01% |
29,045
+1,523
| +6% | +$28.1K |
2020 Q2
11 quarters
|
|
4287
ProShares Ultra Bloomberg Crude Oil
UCO
$397M
| $507K | ﹤0.01% |
19,158
+5,368
| +39% | +$146K |
2018 Q4
17 quarters
|
|
|
GLO
4288
Clough Global Opportunities Fund
GLO
$232M
| $506K | ﹤0.01% |
103,537
+78,311
| +310% | +$386K |
2022 Q4
1 quarter
|
|
4289
PUT
Tilray
TLRY
$559M
| $506K | ﹤0.01% |
+20,000
| New | +$571K |
2023 Q1
0 quarters
|
|
4290
Transcat
TRNS
$841M
| $506K | ﹤0.01% |
5,654
+1,448
| +34% | +$123K |
2019 Q1
16 quarters
|
|
4291
Great Southern Bancorp
GSBC
$863M
| $505K | ﹤0.01% |
9,964
+255
| +3% | +$14.5K |
2013 Q2
39 quarters
|
|
4292
State Street SPDR S&P Telecom ETF
XTL
$566M
| $505K | ﹤0.01% |
6,234
+102
| +2% | +$8.43K |
2016 Q1
28 quarters
|
|
4293
PUT
Wynn Resorts
WYNN
$7.89B
| $504K | ﹤0.01% |
4,500
-303,400
| -99% | -$31.7M |
2021 Q4
5 quarters
|
|
4294
ENI
E
$78.2B
| $504K | ﹤0.01% |
17,970
+4,478
| +33% | +$131K |
2013 Q2
39 quarters
|
|
4295
Bar Harbor Bankshares
BHB
$654M
| $502K | ﹤0.01% |
18,963
-894
| -5% | -$26.5K |
2017 Q3
22 quarters
|
|
4296
Tredegar Corp
TG
$245M
| $501K | ﹤0.01% |
54,833
-24,746
| -31% | -$274K |
2013 Q2
39 quarters
|
|
4297
IDEAYA Biosciences
IDYA
$3.53B
| $500K | ﹤0.01% |
36,423
+8,434
| +30% | +$141K |
2020 Q2
11 quarters
|
|
|
MRSN
4298
DELISTED
Mersana Therapeutics
MRSN
| $500K | ﹤0.01% |
4,863
-10,610
| -69% | -$1.49M |
2017 Q2
23 quarters
|
|
|
RAD
4299
DELISTED
Rite Aid Corporation
RAD
| $499K | ﹤0.01% |
222,798
-42,152
| -16% | -$140K |
2013 Q2
39 quarters
|
|
4300
Aspen Aerogels
ASPN
$487M
| $498K | ﹤0.01% |
66,806
+23,672
| +55% | +$235K |
2020 Q2
11 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.